Corvus Pharmaceuticals Inc buy Oppenheimer Holdings Inc.
Start price
20.03.24
/
50%
€1.67
Target price
20.03.25
€6.45
Performance (%)
7.07%
Price
11.07.24
€1.70
Summary
This prediction is currently active. With a performance of 7.07%, the BUY prediction by Oppenheimer_Holdings for Corvus Pharmaceuticals Inc is trending in the right direction. This prediction currently runs until 20.03.25. The prediction end date can be changed by Oppenheimer_Holdings at any time. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Corvus Pharmaceuticals Inc | 6.524% | 6.524% |
iShares Core DAX® | 1.454% | 0.904% |
iShares Nasdaq 100 | -0.913% | 3.463% |
iShares Nikkei 225® | 2.355% | 3.830% |
iShares S&P 500 | 0.283% | 2.639% |
Comments by Oppenheimer_Holdings for this prediction
In the thread Corvus Pharmaceuticals Inc diskutieren
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $8.00 to $7.00. They now have an "outperform" rating on the stock.
Ratings data for CRVS provided by MarketBeat
Stopped prediction by Oppenheimer_Holdings for Corvus Pharmaceuticals Inc
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€1.65
07.05.24
07.05.24
€7.42
07.05.25
07.05.25
2.91%
11.07.24
11.07.24
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€1.81
17.08.23
17.08.23
-
17.08.24
17.08.24
-6.19%
11.07.24
11.07.24